Imunon, Inc. (IMNN)
0.6399
+0.01
(+1.73%)
USD |
NASDAQ |
Nov 16, 11:45
Imunon Price to Book Value : 1.516 for Nov. 16, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 1.490 |
| November 12, 2026 | 1.508 |
| November 11, 2026 | 1.706 |
| November 10, 2026 | 1.824 |
| November 09, 2026 | 2.091 |
| November 06, 2026 | 2.001 |
| November 05, 2026 | 2.132 |
| November 04, 2026 | 2.148 |
| November 03, 2026 | 2.132 |
| November 02, 2026 | 2.061 |
| October 30, 2026 | 2.155 |
| October 29, 2026 | 1.973 |
| October 28, 2026 | 1.966 |
| October 27, 2026 | 2.075 |
| October 26, 2026 | 2.913 |
| October 23, 2026 | 2.925 |
| October 22, 2026 | 2.961 |
| October 21, 2026 | 2.819 |
| October 20, 2026 | 2.380 |
| October 19, 2026 | 2.333 |
| October 16, 2026 | 2.416 |
| October 15, 2026 | 2.511 |
| October 14, 2026 | 2.463 |
| October 13, 2026 | 2.534 |
| October 12, 2026 | 2.534 |
| Date | Value |
|---|---|
| October 09, 2026 | 2.558 |
| October 08, 2026 | 2.534 |
| October 07, 2026 | 2.700 |
| October 06, 2026 | 2.653 |
| October 05, 2026 | 2.937 |
| October 02, 2026 | 3.032 |
| October 01, 2026 | 3.126 |
| September 30, 2026 | 3.055 |
| September 29, 2026 | 1.487 |
| September 28, 2026 | 1.537 |
| September 25, 2026 | 1.570 |
| September 24, 2026 | 1.504 |
| September 23, 2026 | 1.637 |
| September 22, 2026 | 1.682 |
| September 21, 2026 | 1.593 |
| September 18, 2026 | 1.515 |
| September 17, 2026 | 1.537 |
| September 16, 2026 | 1.570 |
| September 15, 2026 | 1.559 |
| September 14, 2026 | 1.632 |
| September 11, 2026 | 1.637 |
| September 10, 2026 | 1.615 |
| September 09, 2026 | 1.682 |
| September 08, 2026 | 1.715 |
| September 04, 2026 | 1.760 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Altimmune, Inc. | 0.6996 |
| Taysha Gene Therapies, Inc. | 3.766 |
| Agenus, Inc. | -- |
| Amgen, Inc. | 17.65 |
| Anika Therapeutics, Inc. | 1.280 |
Price to Book Value Related Metrics
| Price | 0.6399 |
| Earnings Yield | -518.7% |
| Market Cap | 2.986M |